{"Abstract": [0], "Pattern": [1], "recognition": [2, 39, 108, 149, 190, 220], "receptors": [3, 9, 77, 83, 89, 93, 100], "(PRRs)": [4], "are": [5, 103], "a": [6], "class": [7], "of": [8, 21, 42, 61, 106, 152, 162, 173, 206, 209, 215, 225], "that": [10], "can": [11, 45, 63], "directly": [12], "recognize": [13, 116], "the": [14, 19, 38, 57, 67, 127, 144, 148, 160, 171, 184, 186, 192, 195, 213, 216, 223], "specific": [15, 35], "molecular": [16], "structures": [17], "on": [18, 72, 147, 218], "surface": [20], "pathogens,": [22], "apoptotic": [23], "host": [24], "cells,": [25], "and": [26, 34, 40, 50, 95, 112, 117, 122, 150, 154, 167, 176, 203, 211], "damaged": [27], "senescent": [28], "cells.": [29], "PRRs": [30, 44, 55, 102, 115, 153, 164], "bridge": [31], "nonspecific": [32, 47], "immunity": [33], "immunity.": [36], "Through": [37], "binding": [41, 151], "ligands,": [43], "produce": [46], "anti-infection,": [48], "antitumor,": [49], "other": [51], "immunoprotective": [52], "effects.": [53, 140], "Most": [54], "in": [56, 97, 182, 200], "innate": [58], "immune": [59], "system": [60], "vertebrates": [62], "be": [64], "classified": [65], "into": [66], "following": [68], "five": [69], "types": [70, 208], "based": [71], "protein": [73], "domain": [74, 81], "homology:": [75], "Toll-like": [76], "(TLRs),": [78], "nucleotide": [79], "oligomerization": [80], "(NOD)-like": [82], "(NLRs),": [84], "retinoic": [85], "acid-inducible": [86], "gene-I": [87], "(RIG-I)-like": [88], "(RLRs),": [90], "C-type": [91], "lectin": [92], "(CLRs),": [94], "absent": [96], "melanoma-2": [98], "(AIM2)-like": [99], "(ALRs).": [101], "basically": [104], "composed": [105], "ligand": [107, 189], "domains,": [109, 111, 133], "intermediate": [110], "effector": [113, 132], "domains.": [114], "bind": [118], "their": [119, 131, 155], "respective": [120], "ligands": [121, 156], "recruit": [123], "adaptor": [124], "molecules": [125], "with": [126], "same": [128], "structure": [129], "through": [130], "initiating": [134], "downstream": [135], "signaling": [136, 165, 193], "pathways": [137, 166], "to": [138], "exert": [139], "In": [141], "recent": [142], "years,": [143], "increased": [145], "researches": [146], "have": [157], "greatly": [158], "promoted": [159], "understanding": [161], "different": [163, 207], "provided": [168], "ideas": [169], "for": [170, 222], "treatment": [172, 224], "immune-related": [174], "diseases": [175], "even": [177], "tumors.": [178], "This": [179], "review": [180], "describes": [181], "detail": [183], "history,": [185], "structural": [187], "characteristics,": [188], "mechanism,": [191], "pathway,": [194], "related": [196], "disease,": [197], "new": [198], "drugs": [199], "clinical": [201, 204], "trials": [202], "therapy": [205], "PRRs,": [210], "discusses": [212], "significance": [214], "research": [217], "pattern": [219], "mechanism": [221], "PRR-related": [226], "diseases.": [227]}